11-08-2006: Sandia National Laboratories and Monsanto Company announced a three-year research collaboration that is expected to play a role in both organizations' interests in biology and bioenergy. The arrangement is aimed at aligning Sandia's capabilities in bioanalytical imaging and analysis with Monsanto's research in developing new seed-based products for farmers, including corn products that may be able to produce more ethanol per bushel. Financial terms of the agreement were not disclosed.
The research, which falls under a five-year "umbrella" cooperative research and development agreement (CRADA), will initially focus on hyperspectral fluorescence imaging and spectral analysis. Researchers from the two organizations will apply Sandia's hyperspectral imaging and multivariate image analysis technology to aid in the study of plant tissue samples of interest to Monsanto.
The research is expected to enhance current crop analytical technologies, offering an additional technological resource to support Monsanto's robust product discovery engine and development pipeline. Monsanto's crop analytics research program has recently played a role in discovering new seed-based products for farmers, including corn hybrids that offer more ethanol-output per bushel and soybean varieties that produce more nutritious oils for consumers.
Sandia researchers in New Mexico will investigate, develop, and further advance the lab's hyperspectral imaging and multivariate data analysis methods and capabilities for agricultural product discovery and development applications. Hyperspectral imaging is an advanced scanning technology that provides significantly more information on a subject of interest than other scanning technologies commercially available today, by detecting microscopic images using a continuous spectrum of light.
This is where you can add this news to your personal favourites
Monsanto Company and Complix NV announced they have entered into a collaboration agreement to evaluate and develop Complix’s proprietary Alphabody® protein technology in the field of agriculture.Alphabodies are a unique class of protein therapeutics that are potentially active against a bro ... more
Monsanto Company and Evogene Ltd. announced a one-year extension to their five-year research and development collaboration focused on identifying key plant genes related to yield, environmental stress and fertilizer utilization in corn, soybean, cotton and canola. The companies recently ann ... more
Evogene Ltd. and Monsanto Company announced the successful completion of the third year of their research and development collaboration.
The goal of this five–year collaboration agreement is to discover genes that could enhance crop yield for farmers in corn, soybean, cotton and canola. Und ... more
In an innovation critical to improved DNA sequencing, a markedly slower transmission of DNA through nanopores has been achieved by a team led by Sandia National Laboratories researchers.
Solid-state nanopores sculpted from silicon dioxide are generally straight, tiny tunnels more than a th ... more
A report recently released by Sandia National Laboratories shows that researchers in 16 Asian countries often use insufficient biosafety practices. Biosafety Level (BSL) 2 practices are often employed for research involving BSL 3 agents. Nearly two-thirds of respondents investigating Japane ... more
Sandia National Laboratories and Monsanto Company announced a three-year research collaboration that is expected to play a role in both organizations' interests in biology and bioenergy. The arrangement is aimed at aligning Sandia's capabilities in bioanalytical imaging and analysis with Mo ... more